2022
DOI: 10.1007/s00234-021-02879-5
|View full text |Cite
|
Sign up to set email alerts
|

Neuroradiological features of the polymorphous low-grade neuroepithelial tumor of the young: five new cases with a systematic review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
36
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 27 publications
(36 citation statements)
references
References 20 publications
0
36
0
Order By: Relevance
“… 8 Regarding the stalk‐like sign, we assume that it reflects several different pathologies, such as tumor infiltration along with the vessels extending from near the brain surface toward the ventricle, peritumoral gliosis caused by long‐standing tumor existence or seizure‐induced oxidative stress, and coexisting FCD, as is the case with polymorphous low‐grade neuroepithelial tumor of the young. 46 Indeed, the coexistence of AG and FCD was pathologically proven in three cases, 25 , 43 including two cases with stalk‐like signs. FCD may cause longstanding seizure/epilepsy, and conversely, a long seizure/epilepsy history may cause regional atrophy and brain parenchymal degeneration around the tumor.…”
Section: Discussionmentioning
confidence: 96%
“… 8 Regarding the stalk‐like sign, we assume that it reflects several different pathologies, such as tumor infiltration along with the vessels extending from near the brain surface toward the ventricle, peritumoral gliosis caused by long‐standing tumor existence or seizure‐induced oxidative stress, and coexisting FCD, as is the case with polymorphous low‐grade neuroepithelial tumor of the young. 46 Indeed, the coexistence of AG and FCD was pathologically proven in three cases, 25 , 43 including two cases with stalk‐like signs. FCD may cause longstanding seizure/epilepsy, and conversely, a long seizure/epilepsy history may cause regional atrophy and brain parenchymal degeneration around the tumor.…”
Section: Discussionmentioning
confidence: 96%
“…Therefore, gross total resection of the tumor may not be enough, and enlarged resection of the tumor with the epileptic zone (EZ) is required. FCD is known to coexist with LEATs (29), and nowadays, an increasing number of studies reported the coexistence of PLNTY and FCD (5,8,30). The double pathology of PLNTY may be more frequent in cases with long seizure duration and drugrefractory epilepsy (30).…”
Section: Discussionmentioning
confidence: 99%
“…FCD is known to coexist with LEATs (29), and nowadays, an increasing number of studies reported the coexistence of PLNTY and FCD (5,8,30). The double pathology of PLNTY may be more frequent in cases with long seizure duration and drugrefractory epilepsy (30). In our study, the peritumoral cortex was obtained in 2 patients (cases a, b) with ER, and peritumoral FCD was observed in case a with drug-refractory epilepsy, which was located in the occipital lobe.…”
Section: Discussionmentioning
confidence: 99%
“…Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is also a WHO grade 1 tumor associated with seizures [49,50]. The PLNTY is characterized by alterations of the mitogen-activated protein kinase-pathway (MAPK pathway) such as a mutation of the gene for the rapid accelerated fibrosarcoma oncogene type B at position 600 (BRAF V600E) or even a gene fusion involving the gene for the fibroblast growth factor receptor 2 or 3 (FGFR2 or FGFR3) in combination with typical histological features, such as oligodendroglioma-like areas, a diffuse growth pattern, as well as the expression of cluster of differentiation 34 (CD34) and oligodendrocyte transcription factor 2 (OLIG2) [50][51][52][53].…”
Section: Pediatric-type Diffuse Low-grade Gliomasmentioning
confidence: 99%
“…The PLNTY is characterized by alterations of the mitogen-activated protein kinase-pathway (MAPK pathway) such as a mutation of the gene for the rapid accelerated fibrosarcoma oncogene type B at position 600 (BRAF V600E) or even a gene fusion involving the gene for the fibroblast growth factor receptor 2 or 3 (FGFR2 or FGFR3) in combination with typical histological features, such as oligodendroglioma-like areas, a diffuse growth pattern, as well as the expression of cluster of differentiation 34 (CD34) and oligodendrocyte transcription factor 2 (OLIG2) [50][51][52][53]. Despite the median age of 15.5 years [49], several patients with PLNTY up to the 6th decade of life have been reported [49,54,55]. Except for one tumor occurring in the third ventricle [52], all tumors described so far are supratentorial cortical or subcortical tumors with most cases localized within the temporal lobes [49,54,55].…”
Section: Pediatric-type Diffuse Low-grade Gliomasmentioning
confidence: 99%